Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Pantelis Tsirkinidis"'
Autor:
STAMATIS J. KARAKATSANIS, MARIA BOUZANI, ARGYRIS SYMEONIDIS, MARIA K. ANGELOPOULOU, SOTIRIOS G. PAPAGEORGIOU, MICHAIL MICHAIL, GABRIELLA GAINARU, GEORGIA KOURTI, SOTIRIOS SACHANAS, CHRISTINA KALPADAKIS, EIRINI KATODRITOU, THEONI LEONIDOPOULOU, IOANNIS KOTSIANIDIS, ELEFTHERIA HATZIMICHAEL, MARIA KOTSOPOULOU, MARIA DIMOU, ELENI VARIAMIS, DIMITRIOS BOUTSIS, NICK KANELLIAS, MARIA N. DIMOPOULOU, EVRIDIKI MICHALI, GEORGE KARIANAKIS, PANTELIS TSIRKINIDIS, CHRYSSA VADIKOLIA, CHRISTOS POZIOPOULOS, ANNA PIGADITOU, EFFIMIA VRAKIDOU, THEOPHANIS ECONOMOPOULOS, LYDIA KYRIAZOPOULOU, MARINA P. SIAKANTARIS, MARIE-CHRISTINE KYRTSONIS, KONSTANTINOS ANARGYROU, MARIA PAPAIOANNOU, EVDOXIA HATJIHARISSI, ELISSAVET VERVESSOU, MARIA TSIROGIANNI, MARIA PALASSOPOULOU, EKATERINI STEFANOUDAKI, PANAYIOTIS ZIKOS, PANAYIOTIS TSIRIGOTIS, GERASSIMOS TSOUROUFLIS, THEODORA ASSIMAKOPOULOU, EVGENIA VERROU, HELEN PAPADAKI, POLIXENI LAMPROPOULOU, MELETIOS-ATHANASIOS DIMOPOULOS, VASSILIKI PAPPA, KOSTAS KONSTANTOPOULOS, THEMIS KARMIRIS, PARASKEVI ROUSSOU, PANAYIOTIS PANAYIOTIDIS, GERASSIMOS A. PANGALIS, THEODOROS P. VASSILAKOPOULOS
Publikováno v:
In Vivo
Background/Aim: Primary mediastinal large B-cell lymphoma (PMLBCL) is an aggressive B-cell non-Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdfaa2c17ffbfa68bcab5fb2b3f627c1
https://europepmc.org/articles/PMC9087089/
https://europepmc.org/articles/PMC9087089/
Autor:
Konstantina Frangia-Tsivou, Pantelis Tsirkinidis, Konstantinos Psathakis, Georgia-Emmanouela Dendrinou, Irini Messini
Publikováno v:
Journal of Bronchology & Interventional Pulmonology. 27:297-300
Autor:
Pavlina Konstantinidou, Maria K. Angelopoulou, Maria Arapaki, Chryssa Vadikolia, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Anastasia Banti, Emmanouil Spanoudakis, Maria Bouzani, Kostas Konstantopoulos, Theodoros Iliakis, Anastasia Sioni, Niki Stavroyianni, Eleftheria Hatzimichael, Vassiliki Pappa, Panayiotis Panayiotidis, Christina Kalpadakis, Sotirios Sachanas, Stavroula Giannouli, Sotirios G. Papageorgiou, Marie-Christine Kyrtsonis, Sofia Chatzileontiadou, Maria Tsirogianni, Marina P. Siakantaris, Evdokia Mandala, Christos Poziopoulos, Eugenia Verrou, Vasiliki Violaki, Elissavet Vervessou, Theodoros Marinakis, Maria Ximeri, Eirini Katodritou, Maria Dalekou-Tsolakou, Despoina Mparmparousi, Maria Dimou
Publikováno v:
Hematological oncologyREFERENCES. 39(3)
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gain
Autor:
Elissavet Vervessou, Evdokia Mandala, Maria Arapaki, Emmanouil Spanoudakis, Niki Stavroyianni, Vassiliki Pappa, Eirini Katodritou, Maria Dimou, Theodoros Iliakis, Theodoros P. Vassilakopoulos, Anastasia Sioni, Despoina Mparmparousi, Panayiotis Panayiotidis, Theodoros Marinakis, Maria Dalekou-Tsolakou, Maria K. Angelopoulou, Chryssa Vadikolia, Pavlina Konstantinidou, Kostas Konstantopoulos, Eleftheria Hatzimichael, Vasiliki Violaki, Pantelis Tsirkinidis, Sofia Chatzileontiadou, Marina P. Siakantaris, Christina Kalpadakis, Anastasia Banti, Maria Bouzani, Maria Ximeri, Christos Poziopoulos, Eugenia Verrou, Sotirios G. Papageorgiou, Marie-Christine Kyrtsonis, Stavroula Giannouli, Maria Tsirogianni, Sotirios Sachanas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dfebb9f038633f5741115c75c71a70e
https://doi.org/10.1002/hon.2842/v2/response1
https://doi.org/10.1002/hon.2842/v2/response1
Autor:
Themis Karmiris, Zois Mellios, Maria Kotsopoulou, Konstantinos Anargyrou, George Karianakis, Eleftheria Hatzimichael, Gerassimos A. Pangalis, Phivi Rondogianni, Evangelos Terpos, Stamatios Karakatsanis, Argyris Symeonidis, Theodoros P. Vassilakopoulos, Eirini Katodritou, Pavlina Konstantinidou, Catherine Mainta, Pantelis Tsirkinidis, Sotirios G. Papageorgiou, Theoni Leonidopoulou, Panagiotis Tsirigotis, Ioannis Kotsianidis, Christina Kalpadakis, Ioannis Datseris, Evridiki Michali, Marie-Christine Kyrtsonis, Anna Pigaditou, Maria K. Angelopoulou, Eleni Variamis, Maria Dimou, Helen A. Papadaki, Meletios-Athanassios Dimopoulos, Maria Arapaki, Effimia Vrakidou, Gabriella Gainaru, Paraskevi Roussou, Vassiliki Pappa, Vassilios Prassopoulos, Christos Poziopoulos, Marina P. Siakantaris, Theodora Assimakopoulou, S. Chatziioannou, Elissavet Vervessou, Dimitrios Boutsis, Kostas Konstantopoulos, Evdoxia Chatziharissi, Maria Papaioannou, Maria Palassopoulou, Chryssa Vadikolia, Maria Tsirogianni, Panayiotis Panayiotidis, Sotirios Sachanas
Publikováno v:
Annals of Hematology.
End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of
Autor:
Theodoros P, Vassilakopoulos, Sotirios G, Papageorgiou, Maria K, Angelopoulou, Sophia, Chatziioannou, Vassilios, Prassopoulos, Stamatios, Karakatsanis, Maria, Arapaki, Zois, Mellios, Sotirios, Sachanas, Christina, Kalpadakis, Eirini, Katodritou, Theoni, Leonidopoulou, Ioannis, Kotsianidis, Eleftheria, Hatzimichael, Maria, Kotsopoulou, Maria, Dimou, Eleni, Variamis, Dimitrios, Boutsis, Evangelos, Terpos, Evridiki, Michali, George, Karianakis, Pantelis, Tsirkinidis, Chryssa, Vadikolia, Christos, Poziopoulos, Anna, Pigaditou, Effimia, Vrakidou, Marina P, Siakantaris, Marie-Christine, Kyrtsonis, Argyris, Symeonidis, Konstantinos, Anargyrou, Maria, Papaioannou, Evdoxia, Chatziharissi, Elissavet, Vervessou, Maria, Tsirogianni, Maria, Palassopoulou, Gabriella, Gainaru, Catherine, Mainta, Panagiotis, Tsirigotis, Theodora, Assimakopoulou, Pavlina, Konstantinidou, Helen, Papadaki, Meletios-Athanassios, Dimopoulos, Vassiliki, Pappa, Themis, Karmiris, Paraskevi, Roussou, Ioannis, Datseris, Panayiotis, Panayiotidis, Kostas, Konstantopoulos, Gerassimos A, Pangalis, Phivi, Rondogianni
Publikováno v:
Annals of hematology. 100(9)
End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of
Autor:
Konstantinos Anargyrou, George Karianakis, Maria Kotsopoulou, Eleftheria Hatzimichael, Pavlina Konstantinidou, Maria Papaioannou, Chryssa Vadikolia, Evangelos Terpos, Katerina Megalakaki, Lydia Kyriazopoulou, Stamatios Karakatsanis, Anna Pigaditou, Theoni Leonidopoulou, Maria Dimou, Eleni Variamis, Michail Michail, Dimitrios Boutsis, Effimia Vrakidou, Gabriella Gainaru, Pantelis Tsirkinidis, Ioannis Kotsianidis, Kostas Konstantopoulos, Paraskevi Roussou, Maria N. Dimopoulou, Maria Palassopoulou, Theodora Assimakopoulou, Panayiotis Tsirigotis, Christina Kalpadakis, Maria K. Angelopoulou, Gerasimos Tsourouflis, Vassiliki Pappa, Evdoxia Hatjiharissi, Sotirios G. Papageorgiou, Theophanis Economopoulos, Themis Karmiris, Argyris Symeonidis, Meletios-Athanasios Dimopoulos, Christos Poziopoulos, Eirini Katodritou, Ekaterini Stefanoudaki, Panayiotis Zikos, Helen A. Papadaki, Marina P. Siakantaris, Theodoros P. Vassilakopoulos, G. Kourti, Maria Tsirogianni, Gerassimos A. Pangalis, Eurydiki Michalis, Panayiotis Panayiotidis, Sotirios Sachanas, Elissavet Vervessou, Marie-Christine Kyrtsonis, Fotios Panitsas
Publikováno v:
Oncologist
Background R-CHOP can cure approximately 75% of patients with primary mediastinal large B-cell lymphoma (PMLBCL), but prognostic factors have not been sufficiently evaluated yet. R-da- EPOCH is potentially more effective but also more toxic than R-CH
Autor:
Maria N. Dimopoulou, Flora N. Kontopidou, Eleni Plata, Efstathios Koulieris, Panagiotis Panagiotidis, Gerassimos A. Pangalis, Maria K. Angelopoulou, Pantelis Tsirkinidis, Xanthi Yiakoumis, Maria Moschogiannis, Dimitra Rontogianni, Penelope Korkolopoulou, Sotirios Sachanas, Panagiotis Tsaftaridis, Christina Kalpadakis, Gerassimos Tsourouflis, Helen A. Papadaki, Marina P. Siakantaris, Theodoros P. Vassilakopoulos, Marie-Christine Kyrtsonis, Stella I. Kokkoris
Publikováno v:
Blood. 132:666-670
TO THE EDITOR: Treatment of splenic marginal zone lymphoma (SMZL) is not standardized due to the lack of prospective randomized trials.[1][1][⇓][2][⇓][3][⇓][4][⇓][5][⇓][6][⇓][7][⇓][8][⇓][9][⇓][10][⇓][11][⇓][12]-[13][13] After ou
Autor:
Eleni Lalou, Vasileios I. Telonis, Anna Zannou, Pantelis Tsirkinidis, Alexander Kanellopoulos, Angeliki Stefanou, John Meletis, Evangelos Terpos, Marie-Christine Kyrtsonis, Panayiotis Panayiotidis, Athanasios Papatheodorou, Zacharoula Galani, Georgios Boutsikas, Maria K. Angelopoulou, Anastasia Meletiou, Theodoros P. Vassilakopoulos, Nora-Athina Viniou, Panayiotis Tsirigotis, Panayiotis Tsaftaridis
Publikováno v:
European Journal of Haematology. 100:131-139
OBJECTIVES As the interaction between hematopoietic stem cells (HSCs) and endosteal and endothelial niches in HSCs homing is essential, we aimed to study bone turnover and angiogenesis in 29 patients with lymphoma/multiple myeloma undergoing hematopo
Autor:
Kirsten Fischer, Theodoros P. Vassilakopoulos, Barbara Eichhorst, Vassiliki Bartzi, Efstathios Koulieris, Michael Hallek, Pantelis Tsirkinidis, Xanthi Yiakoumis, Georgia Levidou, Anna-Maria Fink, Jasmin Bahlo, Christina Kalpadakis, Marie-Christine Kyrtsonis, Maria K. Angelopoulou, Gerassimos A. Pangalis, Maria Moschogiannis, Sotirios Sachanas
Publikováno v:
Anticancer research. 39(5)
Background: Only few studies have focused exclusively on patients with small lymphocytic lymphoma (SLL). Patients and Methods: In the present report, 103 SLL patients were analyzed from both, clinical trials of the German Chronic Lymphocytic Leukemia